decisionhealth Newsletters, Coder Pink Sheets - 2006 Issue 5 (May)
Use 83037 for new A1C test
Subscribe or sign in to view the full article.
Article Overview
This article discusses a new diabetes laboratory coding update centered on a home-use A1C test and how it is handled in different payment and coverage contexts. It is aimed at coders, pediatric practices, and other billing staff who need to understand the broader coverage environment, CLIA-related considerations, and the distinction between similar lab tests. The article also references several FDA-cleared test systems associated with the code and notes a Medicare modifier commonly used with this type of service.
Why This Topic Matters
Correctly identifying this coding update helps avoid confusion between similar laboratory tests, supports cleaner claims submission, and reduces the risk of payer denials when home-use testing is performed in office or other settings.
Article Sections
-
Home-use A1C testing and payer considerations
Introduces the new diabetes-related lab test and discusses how coverage and payment considerations may differ across payers and settings.
-
Related lab testing distinctions
Highlights the need to distinguish the A1C-related test from other commonly confused laboratory testing categories.
-
2006 CPT/HCPCS update and associated test systems
Summarizes the coding update and lists example FDA-cleared home-use test systems associated with the service.
What You Will Learn
- How a home-use diabetes laboratory test is discussed in relation to payer coverage
- Why similar laboratory tests can be confused in coding workflows
- Which general types of test systems were associated with the coding update
- What coverage-related considerations are mentioned for Medicare and private payers
Who Should Read This
- Medical coders
- Billing staff
- Pediatric practice administrators
- Laboratory billing specialists
Codes Discussed
Modifiers Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com